July 24, 2015 / 5:58 AM / in 2 years

BRIEF-Bausch + Lomb confirms submission of Vesneo(TM) NDA to US FDA

July 24 (Reuters) - Nicox Sa :

* Noted the confirmation by Valeant Pharmaceuticals International Inc‘s., wholly owned subsidiary, Bausch + Lomb, that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for Vesneo(TM)

* Nicox’s advanced pipeline, partnered with Bausch + Lomb / Valeant, features Vesneo(TM), a pre-NDA candidate for glaucoma

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below